Antisera were raised in rabbits against pyocins of different strains of Pseudomonas aeruginosa, which inhibited their anti-pseudomonas bactericidal activity. Utilizing five pyocins of comparable bactericidal titer in a standard assay system, absorption studies with these antisera were performed. Within these five pyocins, absorptions demonstrated not only shared, but also unique, antigenic specificity which divided the five into two types. This type specificity could not be correlated with serogroup of the producing organism but showed a correlation with bactericidal specificity of the pyocins and pyocin susceptibility of the producing strains. Serum from five patients convalescent from P. aeruginosa infection contained antipyocin activity, the specificity of which in two instances reflected the pyocin antigenic types described for rabbit antisera. These observations suggest an antigenic relationship between pyocins of P. aeruginosa that correlates to some degree with the specificity of their bactericidal activity and may reflect the structural characteristics responsible for this activity.
Bacteriocins are substances produced by a variety of different bacteria that can kill selected strains of their own or closely related species (10) . Based upon studies of bacteriocins produced by a limited number of bacteria, these chemicals are felt to be protein in nature and, in at least some instances, to exist as part of a molecular complex involving carbohydrate and/or lipid (9) . It has been established that the bacteriocins produced by Escherichia coli (colicins) are antigenic, eliciting in the experimental animal antibodies that neutralize their bactericidal activity (1, 7) .
The patterns of anti-pseudomonas bactericidal activity by the bacteriocins of Pseudomonas aeruginosa (pyocins) have proven to be adequately heterogeneous to serve as a means of typing strains of that species for epidemiological studies (5, 6, 11) . Furthermore, there has recently been considerable interest in the serological response of human beings to surface antigens of P. aeruginosa developing during the course of naturally acquired infection, both as an epidemiological tool and a diagnostic aid (2) (3) (4) . It therefore seemed that some information on the antigenic nature of pyocins was needed to help explore relationships between structure and patterns of pyocin activity and to explore the possible implications of human serological response to these pseudomonasrelated molecules. Pyocin production. A portion of an overnight growth of P. aeruginosa in Trypticase soy broth was added to 150 ml of the same broth in a 300-ml nephelo culture flask (Bellco Glass Inc., Vineland, N.J.) until the optical density read at 660 nm in a Coleman Junior spectrophotometer had risen to 0.02. The nephelo flask was incubated with shaking at 35 C for about 1.5 to 2 h, at which time the optical density of the medium had routinely risen to 0.06 to 0.08. At this time, 150 ,g of mitomycin C (Sigma Chemical Co., St. Louis, Mo.) was added, and the incubation was continued until lysis of the culture was evident from a falling optical density, which usually occurred within 4 to 6 h. The culture was then centrifuged at 2,000 x g for 30 min and dialyzed overnight against 5 liters of physiological saline at 5 C. The dialysate was concentrated to 5 ml by evaporation through tubular dialysis membrane (Union Carbide Corp., Chicago, Ill.) at 5 C, and the concentrate was then sterilized by filtration through a 0.22-nm pore size membrane filter (Millipore Corp.). Sterility was verified by culture on blood agar, and the absence of bacteriophage was verified by replicate plating (5) . The resulting sterile concentrate of the dialyzed culture filtrate, desig-318 on October 10, 2017 by guest http://iai.asm.org/ Downloaded from nated "pyocin," was used without further fractionation or purification.
Antisera. Antisera to these pyocin preparations were induced in male or nonpregnant female 5-to 7-lb (ca. 2.3-to 3.2-kg) New Zealand white rabbits. A 0.5-ml volume of the pyocin preparation was emulsified with 0.5 ml of complete Freund adjuvant (Difco) and injected in multiple sites subcutaneously between the scapulae at weekly intervals for a total of 3 weeks. One week after the final injection, the animal was exsanguinated by cardiac puncture, the resultant blood was allowed to clot, and the serum was harvested after centrifugation. All sera were stored at -20 C and deactivated by heating to 56 C for 30 min just prior to use.
Pyocin quantitation. Pyocin quantitation is expressed in terms of bactericidal activity, which was determined in the following manner. An overnight culture, in Trypticase soy broth, of a P. aeruginosa strain susceptible to the bactericidal activity of the pyocin under investigation ("indicator strain") was adjusted by dilution to an optical density of 0.2 at 660 nm in a Coleman Junior spectrophotometer. One part of this diluted culture was quickly mixed with 39 parts of Trypticase soy agar at 45 C, and 20 ml of the resulting suspension was allowed to harden in a sterile, plastic petri dish (150 by 15 mm; Labtek Products, Naperville, Ill.). Holes l/8 inch (ca. 0.33 cm) in diameter were punched with a hollow, flame-sterilized, stainless-steel tube, and wells were created by the aspiration of agar plugs so produced. Pyocin or pyocin-antibody mixture was added to each well with sterile glass tubes pulled to a capillary tip, so that the resulting meniscus was even with the surface of the agar. After incubation of the plate overnight at 35 C, colonies developing on or at the agar surface provided a uniform "lawn" of growth. The presence of pyocin activity was detected as a halo of no growth on or in the agar surrounding the pyocin-containing well, which was routinely evaluated by use that incubation of the pyocin-antiserum mixture at 37 C or holding it at 5 C for 18 h did not alter the results obtained with the shorter incubation period. Results were recorded as the highest dilution of antiserum that completely blocked antibacterial activity of the pyocin used. In studies of specificity of antipyocin activity, absorptions of antisera with pyocins were used. In these tests it became necessary to determine the point of equivalence between antiserum and the pyocin being used for absorption, since the absorbing pyocin in excess produced a zone of inhibition if it was bactericidal for the indicator strain. Accordingly, this point of equivalence was determined by serial dilution at very small intervals (e.g., 1:32, 1:34, 1:36, etc.) and was chosen as that ratio which just failed to give a zone of inhibition within the pour plate. To determine activity of the absorbed antisera, serial dilutions of the pyocin to be tested (indicator pyocin) in phosphate-buffered saline were made in a microtiter plate. To each dilution an equal volume of the absorbed antiserum, unabsorbed antiserum equivalently diluted with phosphate-buffered saline, or nonimmunized rabbit serum so diluted with phosphate-buffered saline was added, mixed, and incubated as above prior to filling of the agar wells. Controls included absorbed antiserum added to phosphate-buffered saline to verify the presence of slight antibody excess and to exclude antibacterial activity of the antiserum itself. Results were recorded as the titer of the indicator pyocin in the presence of these various types of sera.
Pyocin typing and serotyping. Assessment of the interaction between pyocin and pseudomonas strains was determined in the usual manner. In each instance the pour plate method as outlined above was used and the pyocin was considered to be active, or the indicator strain to be susceptible, if inhibition of growth under these conditions was obtained by pyocin diluted at 1:40 or more. P. aeruginosa serotypes were determined with eight serotyping antisera produced in rabbits and kindly supplied by M. M. Fisher of the Parke Davis Company. A routine microflocculation test performed in glass plates in moist chambers and read by a steroptic microscope was used.
RESULTS
Antipyocin antibody in the rabbit. Immunization of rabbits with pyocin-containing culture filtrates emulsified with complete Freund adjuvant resulted in the production of antisera that were highly inhibitory to pyocin activity, as previously shown in studies of colicins (1, 7 To explore the impact of quantitative alterations in the absorption procedure on the results obtained in the previous experiments, studies were performed in which the ratio of absorbing pyocin to antiserum was altered, and the ability of the resulting mixtures to neutralize pyocin activity was explored. In these experiments, a strain of P. aeruginosa resistant to the absorbing pyocin was used in the indicator plate. Mixtures with increasing ratios of absorbing pyocin to antiserum were made, and the resulting absorbed antiserum preparations were then titered against a constant dilution of the indicator pyocin. Results of a typical experiment involving pyocin M as the absorbing pyocin, antiserum 225 developed against pyocin 7, and pyocin 7 as the indicator pyocin are shown in Table 2 , with the antiserum titers representing the final dilution of antiserum (including absorption). Increasing the ratio of pyocin M to serum 225 by 1 log did not remove the ability of the absorbed antiserum to neutralize the bactericidal activity of pyocin 7, antiserum titers falling within plus or minus one twofold dilution. These experiments confirm the previous observations and also indicate that, even though significant antipyocin activity remains after absorption, the titer of this residual inhibiting activity is significantly less than that seen when a portion of the antiserum is diluted with saline rather than absorbed. Based on this evidence that pyocins produced by different P. aeruginosa isolates share certain antigenic determinants by which groups of pyocins could be distinguished, it became important to study other typable characteristics of the Pseudomonas organisms involved. Thus, it was important to determine that the members of each pyocin antigenic type were not, in fact, the same pyocins derived from different isolates of the same pseudomonas strain. Furthermore, it became of interest to evaluate possible similarities existing between strains of P. aeruginosa that produced pyocins of similar antigenic type. As a first approach to this problem, serogrouping of the producing P. aeruginosa isolates was performed. Using typing antisera specific for Pseudomonas serogroups 1 through 7 and 17, our Pseudomonas organisms 7 and 8 (which produced pyocins of similar antigenic character as noted above) typed only with the serogroup 2 antiserum. Of our organisms that produced pyocins of the other antigenic type, organism 6 typed with antisera for both serogroups 1 and 17, and 10 and M were identified by none of the typing antisera available to us.
Because of these suggestive but inconclusive data, attention was tumed to pyocin typing of the involved organisms. In these experimernts, both ends of the pyocin-typing procedure were utilized. That is, the P. aeruginosa isolates that produced the five pyocins studied here were screened for their susceptibility to the bactericidal activity of a panel of pyocins. The pyocins produced by these five organisms were then checked for their ability to inhibit a panel of P. aeruginosa isolates. As is apparent from inspection of the data in Tables 3 and 4 , by both criteria P. aeruginosa 7, 8, 10, 6, and M are clearly of different specificity and therefore do represent different strains of P. aeruginosa. Further inspection of these data, however, suggest a degree of similarity between the inhibition patterns within the groups where the pyocins showed antigenic similarity. To test this hypothesis, an analysis of concordance was performed in which the degree of similarity of bactericidal patterns between pyocins or organisms within the same pyocin antigenic type (e.g., 7 versus 8; 10 versus 6 versus M) was compared to the degree of similarity of these patterns between individuals belonging to different pyocin antigenic types (e.g., 7 or 8 versus 10, 6, or M). When the bactericidal specificities of the pyocins belonging to the two different antigenic types (Table 3) were studied in this way, there were 13, 15, 13, and 17 (mean 14.5) concordances of patterns between individuals within the same antigenic type and 12, 12, 10, 8, 8, and 6 (mean 9.3) concordances of patterns between individuals representing different antigenic types. The difference between these means is significant by Student's t test (t = 3.5647; P < 0.01, d.f. 8). A similar analysis of the patterns of sensitivity of the Pseudomonas strains producing pyocins of the two antigenic types (Table 4) revealed concordances of 13, 14, 15, and 15 (mean 14.2) between patterns within the same pyocin antigenic type and 9, 9, 10, 11, 11, and 12 (mean 10.3) between patterns of individuals of different antigenic type. Again, this difference is statistically significant by Student's t test (t = 5.4046; P < 0.001; d.f. 8).
To explore the possibility that pseudomonas pyocins are antigenic in man and in an effort to assess the potential clinical implications of the proposed antigenic types of pyocins, a limited number of sera obtained from patients convalescent from documented P. aeruginosa infections were studied. As controls, sera from individuals whose medical history was well known and did not involve a previous pseudomonas infection were used. When pyocin 7 was titered in the presence of these various human sera at different dilutions, a clear suppression of its bactericidal activity was demonstrable in the presence of sera from infected but not from noninfected individuals (Table 5) . To assess the possible type specificity of this antipyocin activity in human sera, pyocins representing the two proposed antigenic types were titrated ( Table 6 ). As can be seen, antipyocin activity in the serum of patient Mar significantly inhibited both pyocins 7 and M. Antipyocin activity in the serum of patients Czy and Con, however, had a selective inhibitory affect against pyocin 7 , with titrations of pyocin M in their presence showing no detectable difference from control. a Mar, Czy, and Con are sera from patients convalescent from P. aeruginosa infections.
DISCUSSION
It has been documented previously that bacteriocins as protein or protein-containing molecules are antigenic in experimental animals and that the antisera so derived have the power to neutralize their bactericidal activity. No previous effort, however, has been made to study systematically the antigenic composition of these materials. Hutton and Goebel (7) studied antisera raised against two different colicins and detected no antigenic relationship between them. Our studies of the bacteriocins produced by P. aeruginosa (pyocins) have suggested two aspects of such an antigenic characterization. First, it is quite clear that antibodies directed against one pyocin have the ability to neutralize pyocins obtained from a variety of strains of P. aeruginosa. This, in and of itself, suggests that pyocins as a group of molecules sharing a common function also share certain structural characteristics which are expressed as antigenic determinants. In addition, however, these experiments have suggested that there exist at least two antigenically distinct types of pseudomonas pyocins. This conclusion is supported by our observation that antisera raised against a member of one type retain inhibitory activity against pyocins of that type even when extensively absorbed with pyocins of the other. These observations have been substantiated further by the demonstration in sera derived from patients convalescent with P. aeruginosa infection of antipyocin activity which also distinguishes between pyocins of these two types. That we are, in fact, dealing with pyocins derived from different strains of P. aeruginosa is confirmed by differences in susceptibility of the producing strains to a battery of pyocins derived from other Pseudomonas organisms, as well as by differences in the patterns of bactericidal That this apparent typing of pyocins could be due to differences in quantity of pyocin molecules in the pyocin preparations used cannot be completely excluded, since the pyocins were not purified and subjected to another means of quantitation other than their bactericidal activity. Our studies of variations of the absorbing ratio of pyocin to antiserum and the results with human antipyocin sera speak against this alternative possibility.
It is of some interest that pyocins which belong to the same antigenic type seem to have a functional similarity, although not a functional identity. This was shown by a high degree of concordance in the patterns of bactericidal activity of pyocins belonging to the same antigenic type when compared with pyocins of the other type. This raises the possibility that the antigenic determinants involved in specifying these pyocin types are located at or near the reactive site that is important in determining its bactericidal capability. A wide variation in the bactericidal titer of a given pyocin as it affects different strains of P. aeruginosa is commonly observed. Although many explanations can be offered for this variation, it is possible that closeness of fit between the reactive portion of the pyocin molecule and the receptor site may determine the potency of its bactericidal activity. There is, in fact, evidence that pyocins which do not kill a particular pseudomonas still attach to its cell surface (8) . It could be postulated, therefore, that an endless number of structural differences may exist between pyocins, each possibly being antigenically unique to some degree. The similarity in pyocin susceptibility of the Pseudomonas strains producing pyocins of the same antigenic type may be interpreted to suggest a similarity in cell wall receptors, reflecting the structural similarity of the pyocins they produce.
Antigenicity of bacteriocins in experimental animals has been demonstrated previously. The data presented here suggest that pyocins released by Pseudomonas during the course of natural infection in man may also elicit specific antibody. Although we have not proven the antibody nature of this antipyocin activity, the association with infection, their disappearance over a period of time after infection, and the documentation of the antigenicity of these molecules in other mammalian species give support to the hypothesis that antipyocin activity in human serum is antibody in nature. Studies on the molecular nature of this antipyocin activity and its specificity for pyocin produced by the infecting strain have not yet been done. The implications of such an observation in terms of the potential for therapeutic use of pyocins in Pseudomonas infection, diagnosis of presence or persistence of Pseudomonas infections, and seroepidemiological studies of infections by this organism argue for the significance of further investigation in this area.
